Treatment of Netherton syndrome with dupilumab.

Odorici, Giulia; Schenetti, Cecilia; Marzola, Elisa; Monti, Alberto; Borghi, Alessandro; Corazza, Monica

Odorici, Giulia; Schenetti, Cecilia; Marzola, Elisa; Monti, Alberto; Borghi, Alessandro; Corazza, Monica.

Afiliação

Odorici G; Department of Medical Sciences, Section of Dermatology and Infectious Diseases, University of Ferrara, Ferrara, Italy.
Schenetti C; Department of Medical Sciences, Section of Dermatology and Infectious Diseases, University of Ferrara, Ferrara, Italy.
Marzola E; Department of Medical Sciences, Section of Dermatology and Infectious Diseases, University of Ferrara, Ferrara, Italy.
Monti A; Department of Medical Sciences, Section of Dermatology and Infectious Diseases, University of Ferrara, Ferrara, Italy.
Borghi A; Department of Medical Sciences, Section of Dermatology and Infectious Diseases, University of Ferrara, Ferrara, Italy.
Corazza M; Department of Medical Sciences, Section of Dermatology and Infectious Diseases, University of Ferrara, Ferrara, Italy.

J Dtsch Dermatol Ges ; 20(12): 1636-1640, 2022 12.

Article em En | MEDLINE | ID: mdl-36321361

Assuntos

Síndrome de Netherton; Humanos; Síndrome de Netherton/tratamento farmacológico; Fenótipo; Inibidor de Serinopeptidase do Tipo Kazal 5

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Síndrome de Netherton Limite: Humans Idioma: En Revista: J Dtsch Dermatol Ges Assunto da revista: DERMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google